Can the patient sign electronically?

Yes. Electronic signatures are generally enforceable under federal ESIGN and state UETA laws if you document intent, obtain consent for electronic records when required, and retain an accurate reproduction of the signed form.

Is a witness or notary required?

Most routine consent forms do not require notarization, but state or facility rules may require witnesses for specific documents; verify local policy before waiving witness requirements.

How do I correct an error after signing?

Do not alter the signed copy. Prepare an addendum or corrected form, have the signer sign and date the correction, and retain both the original and amendment in the medical record.

Who may sign on a patient’s behalf?

A legally authorized representative, such as a guardian or durable power of attorney for healthcare, may sign if the patient lacks capacity; document authority and relationship in the chart.

What about HIPAA when using an eSignature vendor?

Ensure a Business Associate Agreement is in place if the vendor will create, receive, maintain, or transmit protected health information on your behalf.

Can the patient revoke consent later?

Yes. Patients may withdraw consent; record revocations immediately and document clinical implications and any treatment changes in the medical record.

Electronic Signature
Templates
Healthcare
Healthcare Patient Ozempic Consent Form

Healthcare Patient Ozempic Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Patient Ozempic Consent Form

Patient Information

Patient Name

Date of Birth:

Gender:

Address

Phone Email

Emergency Contact

Insurance Information

Insurance Provider Policy / Member ID Subscriber Name

Medical History and Current Status

Current weight: Height:

Current Medications (include dose and frequency) Allergies (drug, food, other) Prior Surgeries / Significant Medical Events

History of pancreatitis: Yes No

Personal or family history of medullary thyroid carcinoma or MEN2 syndrome: Yes No

Female patients only — current pregnancy or breastfeeding: Yes No

Medication, Indication, and Administration

Medication to be administered: . Intended indication:

Proposed starting dose and schedule:

Route of administration: . Administration location:

Risks, Benefits, and Alternatives

The prescriber has explained the potential benefits of semaglutide (Ozempic), including improved glycemic control and possible weight loss where applicable. I understand that benefits are not guaranteed.

I acknowledge I have been informed of potential risks and side effects, which may include but are not limited to: nausea, vomiting, diarrhea, constipation, abdominal pain, injection-site reactions, hypoglycemia (particularly with concomitant insulin or sulfonylureas), pancreatitis, gallbladder disease, renal impairment, tachycardia, allergic reactions, and a possible increased risk of thyroid C‑cell tumors observed in animal studies. Serious adverse events, including hospitalization and death, have been reported in rare cases.

Alternatives to treatment, including alternative medications, lifestyle modification, and no treatment, have been explained. I have had the opportunity to ask questions about alternatives and the risks and benefits, and all my questions have been answered to my satisfaction.

I understand that if I experience severe abdominal pain, persistent vomiting, signs of hypoglycemia, or signs of allergic reaction (difficulty breathing, swelling, hives), I must seek immediate medical attention and notify the prescribing clinic.

Specific Consents and Acknowledgments

I consent to receive Ozempic (semaglutide) as described above and authorize clinic staff to administer or instruct me in self-administration.

I understand the risks and potential side effects described in this form.

If applicable, the prescriber has discussed off‑label use. I consent to the use of this medication for the indication specified above, including any off-label use when clinically appropriate.

I have received training on injection technique, storage, and disposal and demonstrate understanding of these instructions.

Monitoring and Follow-up

Privacy and Authorization

By signing below I authorize the release of medical information necessary to process insurance claims and to coordinate care relating to the administration of semaglutide. I understand that my health information will be handled in accordance with applicable privacy law and the clinic's privacy policies.

This authorization is valid for the purposes described herein and may be revoked in writing at any time, except to the extent action has already been taken based on this consent. Revocation will not affect disclosures made prior to receipt of the revocation.

Authorization Expiration Date

Patient Statement and Certification

I certify that I have read and understand the information on this form, that the explanations regarding the medication, its risks, benefits, and alternatives were provided to me, and that my questions have been answered. I consent to the proposed treatment and understand I may withdraw consent at any time by notifying the prescribing clinician in writing.

Patient Name:

Signature:

Date:

If signing on behalf of the patient (legal guardian or authorized representative), indicate relationship:

What the Healthcare Patient Ozempic Consent Form Is

The Healthcare Patient Ozempic Consent Form documents a patient's informed agreement to receive semaglutide (Ozempic) therapy and records discussion of benefits, risks, alternatives, dosing, and follow-up. It captures patient identity, medical history relevant to GLP-1 agonists, allergies, and explicit authorization to administer or prescribe the medication. The form also records the clinician’s explanation of adverse effects, monitoring requirements, and the patient’s opportunity to ask questions before signing.

Why a Clear Consent Form Matters for Ozempic

A structured consent form documents informed decision-making, reduces legal and clinical risk, and supports continuity of care. Properly completed forms also help satisfy healthcare record retention and privacy obligations under HIPAA while creating an auditable record of authorization.

Who Typically Completes and Signs This Consent Form

The form is completed by healthcare providers and signed by the patient or authorized representative before initiating treatment.

Primary care physicians and endocrinologists who prescribe Ozempic for glycemic control or weight management.
Nurses, medical assistants, or clinic staff who document counseling and administer injections.
Legal guardians or power-of-attorney holders signing on behalf of an incapacitated patient.

Maintain a copy in the patient’s medical record and provide the patient with a copy per HIPAA and facility policy.

Step-by-Step: How to Obtain Valid Consent

Follow this sequence to ensure the consent is informed, documented, and retained correctly.

01

Verify Identity: Confirm name and DOB against ID and medical record.
02

Explain Treatment: Describe purpose, expected benefit, and dosing schedule.
03

Discuss Risks: Review common and serious adverse effects and alternatives.
04

Obtain Signature: Patient signs and date; record witness or electronic audit details.

How eSigning and eSubmission Works for This Form

Electronic completion follows a standard workflow that preserves evidence of consent while supporting secure transmission and storage.

Upload Document: Clinic uploads the consent form PDF or template to the eSignature platform.
Place Fields: Add signature, date, and required data-entry fields in the correct order.
Authenticate Signer: Choose authentication (email link, SMS code, or stronger method if required).
Capture Audit Trail: Platform records timestamp, IP, and signer actions for the legal record.

Recommended Digital Workflow Settings

Configure the eSignature workflow to support authentication, required fields, and automatic record retention.

Field	Configuration
Signature Field	Required; set signer role to patient or representative
Authentication	Email + optional SMS code for additional verification
Required Fields	Date of birth, medication dose, allergies must be mandatory
Retention	Auto-save signed copy to EHR and secure archive

Technical and Integration Considerations

Choose a platform that supports HIPAA controls, audit trails, and integration with your electronic health record.

File Formats: PDF, DOCX supported
Integrations: Works with EHR, Google Workspace, Box
Authentication: Email, SMS, or advanced methods

Ensure Business Associate Agreement availability if the platform will access protected health information, and confirm retention meets policy.

Security and Compliance Checklist

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

HIPAA: BAA required for protected health information

Audit Trail: Timestamps, IP, and action logs retained

Certifications: SOC 2 Type II and ISO 27001 available

21 CFR Part 11: Support for FDA-regulated record controls

Accessibility: WCAG 2.0 Level AA conformance

Key Risks and Potential Consequences

Invalid Consent: May result in liability

HIPAA Breach: Civil penalties and remediation

Medication Error: Patient harm and professional risk

Regulatory Review: State medical board inquiry

Insurance Denial: Claim payment refusal

Documentation Gaps: Complicates quality audits

Common Preparation and Documentation Mistakes

Leaving required fields blank, such as dose or allergies, which can delay treatment and increase clinical risk.
Using inconsistent patient identifiers across records, causing chart mismatches and billing issues.
Failing to document that alternatives and risks were discussed, weakening proof of informed consent.
Not recording electronic audit details or failing to retain a signed copy per retention policy.

Essential Sections to Include on the Consent Form

A professional consent form groups patient ID, clinical rationale, risks, alternatives, and signatures into clear, auditable sections.

Patient Identification

Full name, DOB, medical record number, and contact information to ensure the form ties to the correct chart and payer records.

Treatment Purpose

Concise statement of why Ozempic is recommended, including therapeutic goals and expected benefits for glycemic control or weight management.

Risks and Side Effects

Plain-language list of common and rare adverse events, with guidance on when to seek urgent care if symptoms occur.

Alternatives

Documented discussion of alternative therapies, lifestyle options, and the option to decline treatment without penalty.

Signature and Witness

Patient or representative signature, date, and witness or verifier details; include electronic audit evidence if e-signed.

Follow-up Plan

Schedule for monitoring, lab tests, and contact instructions for adverse reactions or dose adjustments after initiation.

Timing Considerations and Document Deadlines

Observe timing for consent, follow-up, and recordkeeping to meet clinical and compliance obligations.

Consent Timing:

Obtain informed consent before the first dose or administration.

Follow-up Schedule:

Document planned follow-up visits and monitoring intervals.

Revocation Handling:

Record any patient revocation immediately in the chart.

Adverse Event Reporting:

Report serious events per FDA and facility procedures.

Record Retention:

Retain consent per HIPAA and facility policy.

eSignature Vendor Pricing and Feature Comparison

Compare common plan features and starting price to match platform capabilities to healthcare consent workflows without relying on dated references.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor and plan	Varies by vendor and plan	Varies by vendor and plan	Varies by vendor and plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About Ozempic Consent Forms

Answers to common practical and legal questions about completing, signing, and storing the consent form.

Need help? Contact support

Can the patient sign electronically?
Yes. Electronic signatures are generally enforceable under federal ESIGN and state UETA laws if you document intent, obtain consent for electronic records when required, and retain an accurate reproduction of the signed form.
Is a witness or notary required?
Most routine consent forms do not require notarization, but state or facility rules may require witnesses for specific documents; verify local policy before waiving witness requirements.
How do I correct an error after signing?
Do not alter the signed copy. Prepare an addendum or corrected form, have the signer sign and date the correction, and retain both the original and amendment in the medical record.
Who may sign on a patient’s behalf?
A legally authorized representative, such as a guardian or durable power of attorney for healthcare, may sign if the patient lacks capacity; document authority and relationship in the chart.
What about HIPAA when using an eSignature vendor?
Ensure a Business Associate Agreement is in place if the vendor will create, receive, maintain, or transmit protected health information on your behalf.
Can the patient revoke consent later?
Yes. Patients may withdraw consent; record revocations immediately and document clinical implications and any treatment changes in the medical record.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now